NDC 80425-0171-01 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0171
- Requested NDC
- 80425-0171-01
- Package NDCs from labels
- 80425-0171-3, 80425-0171-2, 80425-0171-1, 80425-0171-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0171-1 | Methocarbamol | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 8 | |
| 80425-0171-2 | Methocarbamol | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | 8 | |
| 80425-0171-3 | Methocarbamol | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0171 | METHOCARBAMOL TABLET, FILM COATED [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 8 | Current NDC, Legacy NDC, 3 package rows | 20250101_c9600cc9-7e27-6e19-e053-2995a90ab024.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0171-1 | EA - Each | 80425-0171 | cdc53f27-e0d3-4ffb-8af5-d419758d22bc | 1 | 2023-06-06 |
| 80425-0171-2 | EA - Each | 80425-0171 | 04ca45d9-2d21-4e99-8b9a-247d01ab4b7b | 1 | 2023-06-06 |
| 80425-0171-3 | EA - Each | 80425-0171 | afb9cb2e-d86c-48b1-bb44-f5928747d6fe | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 39bc9ecf-837e-5bb8-e063-6394a90a917e | 2025-11-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 9aed8304-fa4e-49d6-bd81-fcb3e4cc6173 | 2025-10-16 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PHOENIX RX LLC | 414b2fe0-fa2b-2b18-e063-6394a90ab2b9 | 2025-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | ff55df39-e314-4120-8fab-3757cbe5a872 | 2025-10-16 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | 069045f1-d699-41d0-b674-cdb71cd5fbd0 | 2025-10-15 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | f7ab7f11-9b5a-4d3a-a8fc-eee55b1fc006 | 2025-10-13 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Bryant Ranch Prepack | fdea0332-1ad8-40ef-8cb9-b3c46588155d | 2025-10-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Sagent Pharmaceuticals | 01e7e2c7-49eb-4afb-a496-f2bd901622e9 | 2025-09-29 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Solco Healthcare LLC | 32863f21-30ff-4a8b-a2e6-8ab14a37af0d | 2025-09-25 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6ca768bf-5095-4148-82d2-a0c2dec16d87 | 2025-09-16 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Bryant Ranch Prepack | dfb0e2ee-fd87-4100-9d44-f7a091e73a6c | 2025-09-12 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Doc Rx | 5e55526f-bb34-4b67-85ea-b2765e8066bb | 2025-09-04 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | PHOENIX RX LLC | 3b199152-bafc-e14a-e063-6394a90ab283 | 2025-07-29 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | f07c0a35-fb5d-43a1-a33e-d6a51a5fcd77 | 2025-07-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | 5f746f0f-e884-46d9-a104-529293b0fb90 | 2025-07-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | ff572473-90e3-4f3b-a40e-8b97b86d327b | 2025-07-16 | Warnings, Adverse reactions | ANDA208507 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2025-07-08 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | fe872a3a-fb14-4a0a-b9e4-c9f1885b4978 | 2025-06-18 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Granulation Technology, Inc. | 70c5342c-9597-4fe6-863c-f8ae4adc063a | 2025-06-10 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Golden State Medical Supply, Inc. | c67d3e2b-92cd-1b97-e053-2a95a90af36f | 2025-06-10 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.